Clinical Trials · NCT04615910
A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Radboud University Medical Center
- Enrollment
- 30
- Start date
- Jul 2021
- Locations
- 2 sites, Austria, France
- Primary endpoint
- Pancreatic 68Ga-exendin uptake